OCD (Ortho-Clinical Diagnostics) claims US first for hepatitis assay
This article was originally published in Clinica
The US FDA has approved for sale what is claimed to be the first assay for determining immunity to the hepatitis B virus (HBV) using a random access immunoassay analyser.
You may also be interested in...
Revised bill released by the US Senate Finance Committee adjusts the manufacturer discount program in Medicare Part D and includes new provisions aimed at easing beneficiary cost sharing obligations.
Through a draft guidance, the US agency has established performance criteria for magnetic resonance coils, making the devices eligible for the standards-based Safety and Performance Based Pathway.
Singapore recalls trigger international reaction as metformin is added to growing list of chronic medications found to contain NDMA.